MSRP IN METABOLISM, DIABETES, DIGESTIVE AND KIDNEY DISEASES

AMARA SARWAL FY24 IPA

BRAD ADAMS IPA FY24

GUO WEI IPA FY24

MCKENNA NEVERS IPA FY24

RENAL OUTCOMES WITH THE USE OF VALPROIC ACID IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

YE, XIANGYANG FY2023 IPA

MSRP IN METABOLISM, DIABETES, DIGESTIVE AND KIDNEY DISEASES

A STUDY OF THE PREVALENCE OF APOLIPOPROTEIN L1 (APOL1) ALLELES AMONG INDIVIDUALS WITH PROTEINURIC KIDNEY DISEASE WHO ARE OF RECENT AFRICAN ANCESTRY OR GEOGRAPHIC ORIGIN. PROTOCOL VX19-NEN-801

BRAD ADAMS FY23 IPA

GUO WEI FY2023 IPA

KAYLENE ZUPAN FY23 IPA

ROBERT BOUCHER IPA 2023 ORH

WEI FY23 ORH VA IPA

YE, XIANGYANG FY2023 IPA

YE,XIANGYANG FY2023 IPA FL VA

FINE-REAL: A NON-INTERVENTIONAL STUDY PROVIDING INSIGHTS INTO THE USE OF FINERENONE IN A ROUTINE CLINICAL SETTING

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER PHASE 3 STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF FINERENONE, IN ADDITION TO STANDARD OF CARE, ON THE PROGRESSION OF KIDNEY DISEASE IN PATIENTS WITH NON-DIABETIC CKD

REMOTE MONITORING AND VIRTUAL COLLABORATIVE CARE FOR HYPERTENSION CONTROL TO PREVENT COGNITIVE DECLINE

OBJECTIVELY MEASURED SEDENTARY BEHAVIOR AND PHYSICAL ACTIVITY IN PREVENTABLE STUDY

ZEUS - EFFECTS OF ZILTIVEKIMAB VERSUS PLACEBO ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION

SIT LESS, INTERACT AND MOVE MORE (SLIMM) 2 STUDY

NIDDK T35 RENEWAL (FISHER)

IPA - JUDY CARLE

FLOW - EFFECT OF SEMAGLUTIDE VERSUS PLACEBO ON THE PROGRESSION OF RENAL IMPAIRMENT IN SUBJECTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE